Arkolith/Insider Trading/TLSI/Form 4

Marshak Richard

Chief Commercial OfficerTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed May 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$34K
Net Open-Market Flow
-$34K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2025Sell(S)7K$5.18$34K69K
May 19, 2025Grant(A)21K$5.18$111K76K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001826667-25-000057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML